Primary prevention of cardiovascular disease using validated risk scores: A systematic review

Objectives The high prevalence of cardiovascular disease (CVD) and the increased cost of treatment have prompted strategies for the primary prevention of CVD in the UK to move towards the use of validated CVD risk scores to identify individuals at the highest risk. There are no reviews evaluating the effectiveness of this strategy as a means of reducing CVD risk or mortality. This review summarizes current evidence for and against the use of validated CVD risk scores for the primary prevention of CVD. Design We utilized an in depth search strategy to search MEDLINE, EMBASE and the Cochrane database of clinical trials, expert opinions were sought and reference lists of identified studies and relevant reviews were checked. Due to a lack of homogeneity in outcomes and risk scores used it was not possible to conduct a meta-analysis of the identified studies. Setting The majority of included trials were carried out in a primary care setting. 2 trials were carried out in North America, 2 in Scandinavia and 1 in the UK. Participants 31,651 participants in total were recruited predominantly from a primary care setting. Participants were aged 18-65 years old and were free from CVD at baseline. Main outcome measures Outcome measures used in the included studies were change in validated CVD risk score and CVD/All-cause mortality. Results We identified 16 papers which matched the inclusion criteria reporting 5 unique trials. Due to a lack of homogeneity in outcomes and risk scores used it was not possible to conduct a meta-analysis of the identified studies. Only one study reported a significant difference in risk score at follow up and one study reported a significant difference in total mortality, however significant differences in individual risk factors were reported by the majority of identified studies. Conclusions This review demonstrates the potential for multifactorial interventions aimed at individuals selected by CVD risk scores for lowering CVD risk and mortality. However, the majority of studies in this area do not provide an intensity of intervention which is sufficient in significantly reducing CVD mortality or validated CVD risk.

[1]  S. Allender,et al.  European cardiovascular disease statistics , 2008 .

[2]  Aziz Sheikh,et al.  Predicting risk of type 2 diabetes in England and Wales: prospective derivation and validation of QDScore , 2009, BMJ : British Medical Journal.

[3]  S. Ebrahim,et al.  Multiple risk factor interventions for primary prevention of coronary heart disease. , 2011, The Cochrane database of systematic reviews.

[4]  T. Greenhalgh,et al.  Effect on smoking quit rate of telling patients their lung age: the Step2quit randomised controlled trial , 2008, BMJ : British Medical Journal.

[5]  L. Bouter,et al.  Microvascular complications at time of diagnosis of type 2 diabetes are similar among diabetic patients detected by targeted screening and patients newly diagnosed in general practice: the hoorn screening study. , 2003, Diabetes care.

[6]  H. Young.  Putting prevention first - vascular checks: risk assessment and management , 2010 .

[7]  M. Mäkelä,et al.  Individualised multifactorial lifestyle intervention trial for high-risk cardiovascular patients in primary care. , 2001, The British journal of general practice : the journal of the Royal College of General Practitioners.

[8]  D. Levy,et al.  Prediction of coronary heart disease using risk factor categories. , 1998, Circulation.

[9]  S. Ebrahim,et al.  Multiple risk factor interventions for primary prevention of coronary heart disease. , 2000, The Cochrane database of systematic reviews.

[10]  T Fahey,et al.  Accuracy and impact of risk assessment in the primary prevention of cardiovascular disease: a systematic review , 2006, Heart.

[11]  GerdAssmann,et al.  Simple Scoring Scheme for Calculating the Risk of Acute Coronary Events Based on the 10-Year Follow-Up of the Prospective Cardiovascular Münster (PROCAM) Study , 2002 .

[12]  Multiple risk factor intervention trial. Risk factor changes and mortality results. Multiple Risk Factor Intervention Trial Research Group. , 1982, JAMA.

[13]  K. Anderson,et al.  Cardiovascular disease risk profiles. , 1991, American heart journal.

[14]  K Khunti,et al.  Features of primary care associated with variations in process and outcome of care of people with diabetes. , 2001, The British journal of general practice : the journal of the Royal College of General Practitioners.

[15]  K. Patel,et al.  Vascular risk checks in the UK: strategic challenges for implementation , 2009, Heart.

[16]  R. Collins,et al.  Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart disease. , 1994, British medical bulletin.

[17]  E. Frank.  Benefits of stopping smoking. , 1993, The Western journal of medicine.

[18]  J. Singer,et al.  One-year follow-up of a therapeutic lifestyle intervention targeting cardiovascular disease risk , 2007, Canadian Medical Association Journal.

[19]  Gladys B. Mutangadura,et al.  World Health Report 2002: Reducing Risks, Promoting Healthy Life , 2004 .

[20]  J. Hippisley-Cox,et al.  Association of deprivation, ethnicity, and sex with quality indicators for diabetes: population based survey of 53,000 patients in primary care. , 2004, BMJ.

[21]  R. Ulvik,et al.  Effectiveness of two preventive interventions for coronary heart disease in primary care. , 1997, Scandinavian journal of primary health care.

[22]  D. Wood,et al.  Randomised controlled trial evaluating cardiovascular screening and intervention in general practice: principal results of British family heart study , 1994 .

[23]  Peter E. Hilsenrath,et al.  The World Health Report 2000 , 2002 .

[24]  P. Schwarz,et al.  Prevention of Diabetes Self-Management Program (PREDIAS): Effects on Weight, Metabolic Risk Factors, and Behavioral Outcomes , 2009, Diabetes Care.

[25]  G. Elwyn,et al.  Personalised risk communication for informed decision making about taking screening tests. , 2013, The Cochrane database of systematic reviews.

[26]  K. Furie,et al.  Heart disease and stroke statistics--2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. , 2008, Circulation.